Toronto Dominion Bank’s VivoSim Labs VIVS Stock Holding History

Toronto Dominion Bank’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-4	Closed	-$11K	–	1087
2013 Q4	$11K	Buy	+4	New	+$7.85K	﹤0.01%	967

Other funds holding VIVS

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Toronto Dominion Bank's VIVS Position: Q3 2024 in Review

Toronto Dominion Bank sold out of VivoSim Labs (VIVS) in Q3 2024, closing a stake of 6 shares — an estimated $58 sold.

Toronto Dominion Bank first reported a position in VIVS in Q2 2022 and held it in 7 quarters. The position peaked at $95 in Q3 2023. 29 funds tracked by Wall St. Rank hold VIVS as of Q3 2024.

Toronto Dominion Bank reported no remaining VivoSim Labs position as of Q3 2024 after selling out during the quarter.
Toronto Dominion Bank sold 6 VivoSim Labs shares in Q3 2024, an estimated $58.
Toronto Dominion Bank first reported a position in VivoSim Labs in Q2 2022 and held it in 7 quarters.
Toronto Dominion Bank's VivoSim Labs position peaked at $95 in Q3 2023.
29 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2024.

Based on Toronto Dominion Bank's 13F filing for Q3 2024, filed 14 Nov 2024.